24 February 2025

LiU-researcher Frank Hernandez has received a grant for his research in designing antibiotics that can be administered with precision. It is one of 23 approved grants by The Swedish Research Council (VR) that focuses on antimicrobial resistance.

Frank Hernandez, Baris Borsa, Anna Carolina Lenhart
Frank Hernandez, Baris Borsa, Anna Carolina Lenhart

His project is developing a new class of drugs based on precision medicine principles. These drugs are designed to target specific organs or tissues, enhancing therapeutic efficacy while minimizing side effects.
“The technology can be used to treat localized infections, such as skin and soft tissue infections, osteomyelitis, endocarditis, and pneumonia, says Frank Hernandez”

The goal is to complete the preclinical phase for an experimental antibiotic and initiate first-in-human studies to bring this innovative technology closer to clinical use.
"This project represents the second phase of our TOUCAN platform development."

TOUCAN Technology, a company co-founded by Frank Hernandez and soon transferred to Theralia AB, integrates conventional drugs with a nano-transport system for targeted delivery. Like a GPS it identifies bacterial infections within the body, delivering treatment with high precision, efficacy, and minimal side effects.
“The nano-transport is a short nucleic acid (e.g., DNA) carrying the drug. It remains inactive in the blood and only activates upon detecting a bacterial infection, releasing the drug to kill bacteria. This makes the drug harmless and safer for other parts of the body. In short, the drug works only where it's needed.”

Although demonstrated in bacterial infections, this approach has potential applications for treating conditions such as cancer and autoimmune diseases.
“The ultimate goal of this project is to begin the validation of TOUCAN technology in human clinical trials through the development of the first targeted antibiotics. Once the pre-clinical phase is completed, we will validate the safety features of the TOUCAN technology in humans, followed by its application in treating infections using this technology”, says Frank Hernandez.


Contact

Latest news from LiU

A tree branch in bloom in front of a building

LiU new on World Reputation Rankings list

For the first time, Linköping University has made it onto the British Times Higher Education magazine’s World Reputation Rankings list.

Portrait (Feng Gao).

Prestigious physics award for Feng Gao

This year's Göran Gustafsson Prize in Physics goes to LiU professor Feng Gao. His research focuses on how new materials can be used for the next generation of solar cells and LEDs, among other things. The total prize money is SEK 7.5 million.

Researcher hold a glowing sheet of glass with tweezers.

Next generation LEDs are cheap and sustainable

Cost, technical performance and environmental impact – these are the three most important aspects for a new type of LED technology to have a broad commercial impact on society. This has been demonstrated by LiU-researchers in a new study.